Abeona Therapeutics Inc. (ABEO) vs Fulcrum Therapeutics, Inc. (FULC)
A side-by-side comparison of Abeona Therapeutics Inc. and Fulcrum Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ABEO
Abeona Therapeutics Inc.
$5.03HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
FULC
Fulcrum Therapeutics, Inc.
$3.70HealthcareDelayed quote: Oct 6, 2026, 12:54 PM EDT
Total return — ABEO vs FULC
growth of $100 · dividends reinvested · last 7yABEO -95.1% (-35.0%/yr)FULC -72.5% (-16.8%/yr)FULC compounded faster over this window
Log scale — wide-divergence pair
ABEO FULC
ABEO vs FULC: by the numbers
- •ABEO is the larger company ($286M vs $282M market cap).
- •Both run net losses; FULC's is the smaller (0.00% vs -246.42% net margin).
Metrics side by side
Valuation
| Metric | ABEO | FULC |
|---|---|---|
| P/S ratio | 11.22 | N/A |
| P/B ratio | 2.24 | 0.91 |
Profitability
| Metric | ABEO | FULC |
|---|---|---|
| Gross margin | 73.68% | 0.00% |
| Operating margin | -1536.91% | 0.00% |
| Net margin | -246.42% | 0.00% |
| ROE | -49.11% | -27.36% |
| ROIC | -49.76% | -27.62% |
Growth (annualized)
| Metric | ABEO | FULC |
|---|---|---|
| Revenue CAGR (5Y) | -10.26% | N/A |
| Total return CAGR (5Y) | -26.46% | -31.70% |
Frequently asked
- How have ABEO and FULC total returns compared?
- Over the past 5 years, ABEO delivered -26.46% and FULC delivered -31.70% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.